Self-renewal and differentiation of stem cells depend on asymmetric division and polarized motility processes that in other cell types are modulated by nonmuscle myosin-II (MII) forces and matrix mechanics. Here, mass spectrometry-calibrated intracellular flow cytometry of human hematopoiesis reveals MIIB to be a major isoform that is strongly polarized in hematopoietic stem cells and progenitors (HSC/Ps) and thereby downregulated in differentiated cells via asymmetric division. MIIA is constitutive and activated by dephosphorylation during cytokine-triggered differentiation of cells grown on stiff, endosteum-like matrix, but not soft, marrow-like matrix. In vivo, MIIB is required for generation of blood, while MIIA is required for sustained HSC/P engraftment. Reversible inhibition of both isoforms in culture with blebbistatin enriches for long-term hematopoietic multilineage reconstituting cells by 5-fold or more as assessed in vivo. Megakaryocytes also become more polyploid, producing 4-fold more platelets. MII is thus a multifunctional node in polarized division and niche sensing.
INTRODUCTION
Stem cells must be able to self-renew and also give rise to diverse cell types by asymmetric division in appropriate microenvironments (Knoblich, 2010) . This differential segregation of cell fate determinants produces progenitors that expand symmetrically to generate tissue. Hematopoietic stem cells (HSCs, as a subset of CD34 + cells) exemplify these key properties of stem cells in that they are often quiescent in niches of the bone marrow (BM), but they and/or their daughter cells polarize and divide asymmetrically in suitable niches to generate progenitors that further divide and specialize to terminally differentiated erythroid, megakaryocyte, and white cell lineages. A number of models for marrow and soluble signal regulation of HSC maintenance and differentiation have been described (Trumpp et al., 2010) , but many physical aspects of hematopoiesis remain unclear. Many cell types apply forces to the matrix that they adhere to, and the flexibility of extracellular matrix is already known to modulate differentiation of marrow-derived mesenchymal stem cells (MSCs) (Engler et al., 2006) as well as the expansion of adult HSCs and progenitors (HSC/Ps) (Holst et al., 2010) . In both of these latter studies, myosin-II (MII) inhibition revealed a key role for actomyosin forces in adhesion and sensing of matrix. However, cell contractile forces contribute to many processes in stem cell and progenitor maintenance and division with likely relationships to differentiation.
Cytokinesis is driven by nonmuscle MII in a cell's cortex, and the asymmetry of stem cell division in C. elegans is also established by MII (Ou et al., 2010) . Differentiation in embryogenesis indeed requires active MII (Conti et al., 2004) , and while inhibition of MII in adherent embryonic stem cells (ESCs) increases survival in culture by preserving intercellular contacts (Chen et al., 2010) , inhibition can also lead to multinucleated cells (Canman et al., 2003) . Actomyosin forces generally stabilize the plasma membrane with an active cortical tension or rigidity (Merkel et al., 2000) , but these forces also drive cell rounding in cytokinesis (Sedzinski et al., 2011) and can change dramatically in differentiation (of MSCs) (Engler et al., 2006) . Indeed, while it has been known for many years that as granulocytes differentiate they become soft to better traffic from marrow through the endothelial barrier and into the circulation (Lichtman, 1970) , any MII changes in such cells leaving the marrow or in other hematopoietic cells is currently unknown.
Mammals express three isoforms of MII: A (MYH9), B (MYH10), and C (MYH14), and each is regulated transcriptionally as well as posttranslationally. MIIA is found in most tissues including blood (Maupin et al., 1994) and is essential to embryonic differentiation (Conti et al., 2004) . MIIB is particularly enriched in brain and cardiac tissues, and it is often polarized to the rear of migrating cells (Vicente-Manzanaresmore slowly from F-actin than MIIA, resulting in higher force generation per MIIB (Wang et al., 2003) . However, MIIB in human ESCs or stem cells in general has unknown functions. MIIC appears restricted to epithelial cells and serves here as a useful negative control in expression analyses. Here, we reveal critical roles of MIIA and MIIB in adult hematopoiesis and use that understanding to enrich highly heterogeneous HSC/Ps for long-term hematopoietic stem cells.
RESULTS

MII Isoforms Switch from B-and-A to Only A in Human Adult Hematopoiesis
Immunofluorescence of human CD34 + cells reveals cortical MIIB as well as MIIA (Figure 1Ai ), but flow cytometry and immunoblots show that myosin levels vary with surface markers and also across differentiated lineages (Figure 1Aii , Figures S1A and S1B, available online). Mass spectrometry-calibrated intracellular flow (MS-IF) cytometry ( Figure S1C , Supplemental Experimental Procedures) was developed to quantify absolute isoform stoichiometry, which is not possible by antibody methods alone due to differential sensitivities of antibodies to isoforms. MS-IF cytometry of diverse hematopoietic cell types reveals that MIIB is no more than $30% of total MII across cell types and has a large dynamic range of $5,000-fold compared to $80-fold for MIIA (Table S1 ). However, MS also revealed MIIA phosphorylation at S1943 (pS1943), which deactivates MIIA through myofilament disassembly (Dulyaninova et al., 2007) , and so a phosphospecific antibody was used to estimate the pS1943 stoichiometry of MIIA through a calibration scheme using mutant GFP-MIIA (see Supplemental Experimental Procedures). Based on this, $50%-60% of MIIA is phosphorylated as pS1943 in the three key HSC/P subpopulations of CD34 + cells ( Figure S1D ) per standard surface markers (Majeti et al., 2007; Novershtern et al., 2011) : . Colors in bar graphs and gene symbols respectively represent power law exponents or gene intensities, and they are normalized by minimum levels (green: 0 or log 2 3) and maximum levels (red: 3 or log 2 11) of correlated genes using MYH10 as a reference (black: 1 or log 2 6). Representative correlation plots between MYH10 and HSC/P (Bii) or differentiation (Biii) gene markers are shown (mean ± SEM of n R 2). See also Figure S1 , Table S1, and Table S2 .
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In differentiation, pS1943 generally decreases as MIIA is activated ( Figure S1D ), except for MKs in which pS1943 is similarly high as in HSC/Ps.
Phosphorylation at S1943 is equivalent to inhibiting $50% of MIIA activity , so that for any cell type, active-MIIA = (50% of total MIIA) 3 (1 + MIIA fraction of nonpS1943). The result for active-MIIA proves to be nearly constant throughout hematopoietic differentiation and makes a useful common denominator. As such, a myosin map of hematopoiesis shows the highest stoichiometric ratio of (MIIB: active-MIIA) z 1:2 (50%) in ''HSC-enriched'' ( Figure 1Aiii ) and a ratio of (MIIB: active-MIIA) R 1:10 for the other marrow-restricted cells that include nucleated erythroid progenitors, MKs, and nonhematopoietic MSCs. For cell types that predominantly exit the marrow, the ratio (MIIB: active-MIIA) generally decreases as MIIB is specifically repressed-except for red blood cells (RBCs), which repress both myosins in similar proportion. Hematopoietic differentiation thus involves a major switch from MIIB + MIIA to active MIIA alone.
The programmatic nature of MII changes in hematopoiesis is evident in the fact that all nine of the marrow-resident cell types measured here cluster together in the MII map (Figure 1Aiii) . Based on the ''marrow'' space in such a map being roughly half as large as that spanned by all measured cell types, we estimate a clustering probability p z ( 1 / 2 )
11
( 1 / 2 ) 5 = 0.000015.
This high significance p provides a metric of the systematic consistency of our MII measurements in addition to revealing a broad MII program. Since MIIB was highest at the protein level in CD34 + subpopulations, microarray profiling of the different stem/progenitor/ differentiated cells allowed us to identify genes that correlate with expression of MYH10 (Figure 1Bi ). CD34 correlated strongly with MYH10 in showing a power law exponent of 1.8 (Figure 1Bii ), whereas the differentiation gene ELANE is strongly anticorrelated with a power law of À1.8 exponent (Figure 1Biii ). MYH9 shows no correlation with MYH10. Transcripts that fit well were further assessed with a second, novel algorithm for a robust list (Table S2) . A key subset is ranked on the correlation with MYH10 and color-coded for the power law. Consistent with protein-level analyses, both MYH9 and MYH10 transcripts are of similar (midrange) intensity. About 1% of MYH10-correlated genes are known HSC/P markers, while >10% of the most anticorrelated genes are specific lineage markers. The profiling indeed shows maintenance of HSC/P markers (e.g., CD34 and ALDH1A1) and suppression of differentiation genes (e.g., ELANE) (Figures 1Bii and 1Biii ). Transcriptome dynamics thus align well with protein dynamics along with the differentiation trajectory.
MIIB Polarization in Marrow-Derived CD34
+ Cells Some of the MYH10-correlated genes (CEP70, DOCK1, MACF1, MAP7, and TUBB4) not only polarize but also have roles in motility via the microtubule system. MIIB might be more cortical than MIIA in round, uncultured CD34 + cells (Figure 2A) , and in the $50% of CD34 + cells that are polarized in culture, MIIB is clearly enriched in the uropod by 75%, while MIIA is diffuse and uniform. The microtubule organizing center (MTOC) was also in the uropod as expected (Giebel et al., 2004) . However, because cytoskeletal polarization in MSCs is suppressed by soft microenvironments , it became important to measure the elasticity of intact BM. Therefore we sectioned fresh bone lengthwise to expose the marrow for probing by atomic force microscopy. We determined a microscale elasticity of $0.3 kilopascal (kPa) ( Figure 2B ), which is >10 6 -fold softer than rigid bone and plastic. HSC/Ps have also been seen to localize at or near the osteoblastic endosteum of bone, which we had previously measured to have an elasticity >30 kPa (Engler et al., 2006) . The softness of marrow is likely a product of both high cellularity and low extracellular matrix density: fibronectin (FN) is ubiquitous in marrow but is denser near the endosteum where collagen-I is also high (Nilsson et al., 1998) . CD34 + cells clearly anchor specifically to FN versus collagen-I
( Figures S2A-S2C ), and so we FN-functionalized gels of polyacrylamide to test matrix elasticity effects on MIIB polarization. Similar to our findings for marrow-derived MSCs , MIIB polarization in CD34 + cells is suppressed in cultures on marrow-mimetic soft matrix but promoted in cultures on endosteum-mimetic stiff matrix ( Figure 2C ). Blebb rapidly abolishes MIIB polarization on stiff matrix without affecting membrane intensity of MIIB. MII activity and stiff matrix (including rigid plastic if cells adhere) thus drive polarization in CD34 + cells.
Local stresses independent of adhesion can polarize MII in Dictyostelium cells that are pulled into micropipettes by aspiration (Ren et al., 2009 ). Hematopoietic cells were likewise aspirated at low stress (<1 kPa) after transfection of GFP-MIIA or MIIB, and within just 20 min, MIIB polarized by more than 10-fold into the stressed projection ( Figure 2D ), while MIIA polarized much less. Importantly, receptors such as integrins do not engage the micropipette wall, and so polarization can indeed be independent of adhesion. Partial knockdown of MIIB in CD34 + cells followed by aspiration also showed greater distension of the membrane as well as membrane fragmentation ( Figure 2E ), and knockdown cells also showed an $20% decrease in migration through a 3 mm pore filter (Figure S2D) . Functionally, MIIB polarization in CD34 + cells is thus protective of membrane shape changes produced by cell forces.
Asymmetric Division Is Biophysically Regulated by MIIB Large cortical tensions are generated in cells as they round up and divide during asymmetric division (Sedzinski et al., 2011) . Because MYH10 correlates with a half-dozen genes involved in asymmetric division of hematopoietic cells (Ting et al., 2012) (Table S3) , confocal imaging and partial knockdown ( Figure 3Ai ) were used to assess MIIB in asymmetric division of CD34 + cells (Figure 3Aii ), which occurs in $30% of cells (consistent with Lordier et al., 2012) . MIIB enriches toward the CD34 hi daughter cell, concentrating near the cleavage furrow by $3-fold (Figure 3B) , whereas CD34 appears segregated between cells but otherwise locally homogenous, consistent with lateral mobility of this membrane protein. The results suggest that high cortical tensions in the cleavage furrow have a similar effect on receptorindependent localization of MIIB as that of local stressing by a micropipette.
Partial knockdown of MIIB abolishes the asymmetry and also the segregation of CD34 ( Figure 3B, (Hawkins et al., 2007) shows that partial knockdown of MIIB increases the number of CD34 + CD38 À cells by 2-fold ( Figure 3Ei) or for CD34 + CD38 + cells by 1.5-fold (Figure 3Eii ), whereas CD34 À numbers remain unaltered (Figure 3Eiii ). On the other hand, partial MIIA knockdown ($30%) did not alter numbers of any subpopulations ( Figure S2E ). The data reveal MIIB as a major factor in asymmetric division and differentiation of CD34 + cells to CD34 À cells.
MIIA Dephosphorylates in Differentiation to a Mechanically Active State
MIIA is often the dominant MII isoform and can influence MIIB , which implies that phosphoregulation of MIIA can in principle influence hematopoiesis ( Figure 4A ). We therefore examined regulation by niche factors of pS1943 in CD34 + cells and found the highest levels of pS1943 in uncultured CD34 + cells (Figure 4Bi ; Figure S1D ), with levels systematically decreased upon differentiation with Thrombopoietin (Tpo) and Granulocyte-Colony Stimulating Factor (G-CSF), but not Stem Cell Factor (SCF) alone (Figure 4Bii ). Transforming Growth Factor-b (TGF-b) promotes HSC hibernation (Yamazaki et al., 2011) and blocks the decrease in pS1943 with cytokines (Figure 4B) . Remarkably, Blebb mimics TGF-b ( Figure 4B ). In contrast, very low pS1943 in myeloid CD33 + cells ( Figure S1D ) and in the human monocytic cell line (THP-1) are consistent with rapid proliferation of THP-1 in suspension (which can be blocked by Blebb). Both CD34 + and CD34 À cell numbers anticorrelate with the level of pS1943, and the half-maximal effect was observed at $35% pS1943-MIIA ( Figure 4B ). MIIA is thus modulated by cytokines critical to precirculation differentiation. For the left and right panels, protein intensity was measured across the cell diameter (representative images and diameters are shown). For the middle panel, cortical intensity was measured clockwise (arrow) from the front of the cell origin (''0''). ''Front'' is the summed intensity over contour in the first and fourth quadrants ($50% of the total contour), while ''Rear'' is the summed intensity over the remaining contour.
(B) Measurement of in situ marrow elasticity by atomic force microscopy (AFM). Young's modulus E marrow is obtained from indentation measurements performed at different locations across the exposed marrow samples. The force versus indentation curves are fit by
, where d is the indentation, n is the Poisson ration (assumed to be 0.5), and a is the half opening angle of the AFM tip (Sneddon, 1965) . For all image analyses, n R 10 each sample, two donors, mean ± SEM, and *p < 0.05. See also Figure S2 .
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repopulation'' of human xenografts injected into the femurs of NSG mice for which ''HSCs were operationally defined by lymphomyeloid engraftment that persisted for at least 20 weeks after transplant.'' Standards for mouse HSCs differ from those of human (Doulatov et al., 2012) , but 12-16 weeks is currently considered as ''long-term engraftment'' (Oguro et al., 2013) . We injected directly into marrow rather than into blood to avoid any potential effect of knockdown on trafficking from blood to marrow. Human cells in mice were identified by dual immunostaining for hCD45 and hCD47 ( Figure S3A ), since human RBC and platelets do not express hCD45 while hCD47 confers immunocompatability to all human cells within NSG mice (Rodriguez et al., 2013; Takenaka et al., 2007) . Partial permanent MIIB knockdown (by $40%) ( Figure 5Aii ) leads to 3-fold greater retention of cells in marrow when they are assayed just 16 hr after marrow injection ( Figure 5Bi ); this could reflect the fact that knockdown impairs migration through constraining micropores by 20% (p < 0.05; Figure S2D ). Despite this initial retention advantage, the percentage of human peripheral blood (PB) cells in circulation at 6 weeks after transplantation is 7-fold lower for the MIIB knockdown cells (Figure 5Bii ), and the difference is maintained after 20 weeks (Figures 5Ci and 5Cii ). Sustained engraftment is evident in control mice with significant human cell numbers in marrow and four of five mice showing human cells in PB. In contrast, MIIB knockdown cells were 6-fold more abundant in marrow, but only one of five mice had human cells in circulation. MIIB is thus required to generate PB cells. Because MIIA is the dominant isoform in hematopoietic cells and is phosphoregulated distinctly in marrow cells versus PB cells, we characterized MIIA contributions to hematopoiesis by performing competitive transplants of BM from tamoxifeninducible cre-Myh9 knockout mice. These conditional knockout cells (with surface marker CD45.2) were mixed 1:1 with cells from scaled by stiff matrix (34 kPa) increase with fibronectin (FN) density unless MII is inhibited. For CD34 + CD38 À , EC 50 $22.4 mg/ml, *p < 0.05 (n R 3, ±SEM). See also Table S4 .
Myosin-II Regulates Adult Hematopoiesis wild-type mice (CD45.1) and injected into sublethally irradiated recipient mice (CD45.1) (Figure 5Di ). This knockout strategy with mouse cells instead of human cells proved necessary for understanding MIIA because our in vitro results for proliferation indicated no effect with partial knockdown of MIIA in contrast to major defects with MIIB partial knockdown ( Figure 3A) . At 8 weeks after transplantation of the mixed cells, the total percentage of donor and competitor blood cells was $50% each, and upon tamoxifen treatment, MIIA decreased as expected only in CD45.2 donor cells (Figure 5Dii ). In PB, donor myeloid cells decreased rapidly compared to lymphoid cells (t 1/2 = $30-40 hr versus $20-25 days) ( Figure 5E ), but these half-lives are within 2-fold of those reported for both myeloid (Basu et al., 2002; van Furth and Cohn, 1968) ) of the LSK population also increased just 3 days after Myh9 deletion ( Figure 5G ), although the total LSK number remained unchanged at this time point ( Figure 5F ). Irreversible loss of MIIA therefore suppresses differentiated cell numbers in the long term as defective HSC/Ps progressively apoptose. (CD45.2) and from WT competitor (CD45.1) were transplanted at a 1:1 ratio into lethally irradiated WT recipients. (Dii) Eight weeks after reconstitution, mice were treated with tamoxifen to delete Myh9 as assayed by protein expression (*p < 0.01, control versus tamoxifen, n R 3, ±SEM for all graphs). Deletion occurred with t 1/2 = 9.6 days. n R 8 mice for each group from two independent experiments (±SEM for all graphs). 
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Please cite this article in press as: Shin et 2013.10.009 Transient Inhibition of MII with Blebbistatin Spares Only Long-Term Multilineage Reconstituting Cells Blebbistatin is a reversible inhibitor of all MII isoforms, and dose-response studies of CD34 + cultures show that it has a surprising but understandable effect: the diploid ''HSC-enriched'' population (as phenotypically defined per Majeti et al., 2007 and Novershtern et al., 2011) proves relatively stable to a 3-day treatment, which is long relative to the cell cycle, while the Blebb-treated MPP and CPP are depleted by 1.8-fold (±0.5) and 31-fold (±16), respectively. By suppressing only the progenitors and sparing the HSC-enriched population, the net effect is an enrichment of the latter among total CD34 + cells by up to 16-fold (Figure 6Ai ). Whole-genome transcript profiles indeed show that Blebb cultures correlate well with fresh HSC-enriched cells and MPP, but not CPP (Figure 6Aii , Table S4, and Table S5 ), whereas control CD34 + cultures correlate with fresh CPPs. Blebb treatment beyond 3 days showed a progressive decrease in the HSC-enriched population, consistent with the conditional knockout studies above that suggest that MIIA is essential for hematopoiesis in vivo (Figures 5D-5F ).
Functional tests of HSC enrichment by Blebb were conducted after washing out the drug and involved measuring the frequency of human cells in NSG mice after limiting dilution serial transplantations into multiple primary and secondary recipients (Figure 6B) . A total duration of 32 weeks in primary plus secondary xenografts was chosen as sufficient to assess long-term (Table S4 and Table S5 ). input and fit to dose-response curves. IC 50 , Hill coefficient for CFU-E, 2n: 8.7 mM, À4.4 and 4n: 12.9 mM, À6.3; BFU-E, 2n: 10.9 mM, À9.7, 4n: 13 mM, 28, and Poly R 8n: 0.2 mM, 2.0. (n = 2, ±SEM). See also Figure S3 , Table S4, and Table S5 .
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Myosin-II Regulates Adult Hematopoiesis multilineage engraftment of human HSCs in NSG mice (Notta et al., 2011) . Our blood analyses 16 weeks after primary transplantation showed that positive engraftment required fewer CD34 + cells ($1 in 10,000) from Blebb-treated cultures compared to control cultures (Figure 6Bi ; Figure S3B ). If longterm multilineage engraftment were due solely to progenitors (such as MPPs), then the fact that Blebb-treated cultures have relatively fewer progenitors ( Figure 6A) Figure S3D ), indicative of engraftment, and Blebb results also compare well to uncultured CD34 + cells in previous studies (Nishino et al., 2011) . Sustained secondary engraftment provides an assay for cells with appropriate stem cell properties (Doulatov et al., 2012; Notta et al., 2011; Oguro et al., 2013) and our secondary transplantation results show that Blebb maintains a higher fraction of the HSC-enriched population compared to untreated cultures ($5-fold once again). Both treated and control human CD34 + transplants produced a similar percentage of multilineage myeloid and lymphoid cells ( Figure 6Biii ) and a minor fraction of enucleated human RBCs in the NSG mice (Figure 6Biv ). The latter were enriched by flowing blood through a microfluidic channel coated with anti-hCD47 and then staining for the erythroid-specific marker hGPA ( Figure S3C ). MKs are unique among blood cells in being naturally polyploid and become more so in vitro with Blebb treatment, which also increases in vitro proplatelet formation . In the NSG mice, human platelets (CD41 + ) showed two phases of circulation up to 2 weeks after transplantation that also seemed to benefit from Blebb treatments ( Figure 6C ). In phase I, human platelets are released into the circulation almost immediately and reach an initial peak between $1-20 hr, consistent with intravenously infused MKs ( Figure S3E ) . Phase II peaks at $20-90 hr and reflects a successful lodging of MKs in the marrow. Importantly, human cells treated with Blebb generate more human platelets per transplanted CD41 + cell by about 4-fold in both phases, and shear forces appear to be important in regulating the size of human platelets derived from MKs ( Figure S3F ). Blebb indeed enriches for mature polyploid MKs in culture by $10 fold (Figure 6Di ). For other lineages, the sensitivity of individual progenitor lineages to Blebb proves cytokine dependent ( Figure 5A ; Figure S3G) . For SCF and Tpo CD34 + -derived cells, the IC 50 for CFU-GM is lower than that of BFU-E, with Blebb producing up to a 2-fold higher ratio of BFU-E to CFU-GM (Figure 6Dii ). Erythroid lineages are thus preserved under non-Epo and submaximal MII inhibition. In contrast, when cells are cultured with Epo, both CFU-E and BFU-E numbers are reduced (Figure 6Diii ). Functional studies thus reveal that short-term reversible MII inhibition in combination with specific cytokines enriches for HSCs, mature MKs, and even erythroid progenitors.
Sustained Blebbistatin Induces Apoptosis of Dividing CD34 + Cells via Aryl Hydrocarbon Receptors and p53 Pathways
Control cultures show that CPP and MPP progenitors undergo 2-to 3-fold more divisions as expected compared to the phenotypically marked HSC-enriched population based on CFSE tracking ( Figure 7A ), whereas Blebb-treated cells (20 mM) do not divide. Decay rates of CFSE for CD34 + subpopulations in either the presence or the absence of G-CSF ( Figures S4A  and S4B ) indicate that Blebb accelerates decay, consistent with enhancing cell death. With the phenotypical HSC-enriched population, this is likely due to inhibition of cytokinesis of 4n cells trying to divide at the point drug was added. Apoptosis was measured by cleaved caspase-3 and increased 2-fold with Blebb ( Figure 7B ; Figures S4C-S4F ), although G-CSF modulates survival ( Figure 7B ; Figure S4B ). Suppression of MPP and CPP cell numbers with Blebb is therefore explained by cytokinesis-associated death, which seems consistent with similar roles for MII in apoptosis in C. elegans (Ou et al., 2010) . Transcription profiles of viable fractions from drug-treated and control cells implicate intersecting pathways that involve the aryl hydrocarbon receptor (AHR) and p53 (Table S4) . AHR antagonists counteract apoptosis (Vaziri and Faller, 1997) and expand human HSC/Ps in culture (Boitano et al., 2010) (Figure S5A) . The antagonist CH-223191 improves viability of both control CD34 + and CD34 À cells, specifically the cycling cells (4n) ( Figure 7B ). The number of apoptotic cells with Blebb treatment is also systematically decreased by the more potent StemRegenin-1 (SR1) ( Figure 7C ). Both CH-223191 and SR1 rescue CD34 + cells from cell death by Blebb, since cell numbers approximate control conditions ( Figure 7D ; Figure S5B ). Total p53 protein was then assayed in the presence of Blebb and/or SR1. Total p53 protein increased $2 fold with Blebb but reversed by SR1 ( Figure 7E ). Cyclic-pifithrin-a tests whether induction of apoptosis is dependent on p53-mediated transcription activity (Zuco and Zunino, 2008) . The phenotypic ''HSC-enriched'' population is increased $2-fold with cyclicpifithrin-a in both control and Blebb-treated cells ( Figure 7F ) with an EC 50 close to previous reports (30 nM) (Pietrancosta et al., 2005) . AHR and p53 are thus implicated in Blebb-induced apoptosis.
DISCUSSION
Asymmetric division provides a means to maintain stemness while generating the many differentiated cells required for a tissue with high turnover such as blood (10 5 nucleated cells/s). However, it has been unclear as to how two interconnected daughter cells physically sort components to become distinct. While asymmetry of stem cell division in C. elegans is driven by its one isoform of MII (Ou et al., 2010) , the mammalian homolog, MIIA, is expressed in many cells other than stem cells and unlike MIIB, MIIA polarizes very weakly if at all (Vicente-Manzanares et al., 2008; . Compared to any other hematopoietic lineage, CD34 + cells express the most MIIB relative to MIIA. MIIB polarizes strongly to regions of high cell tension or curvature where it can physically break the symmetry of cytokinesis (Sedzinski et al., 2011) . It is therefore almost predictable that MIIB in CD34 + cells will polarize near a cleavage furrow and define the MIIB hi daughter cell in asymmetric division (Figure 3 ). Since MIIB is localized near the membrane and is known to link to membrane proteins (Clark et al., 2006) , MIIB hi could also help sort cell surface proteins such as CD34 and thereby correlate with CD34 hi as seen. Depletion of MIIB from the CD34 lo daughter cell is also propagated as a
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Please cite this article in press as: Shin et al., Contractile Forces Sustain and Polarize Hematopoiesis from Stem and Progenitor Cells, Cell Stem Cell (2014 ), http://dx.doi.org/10.1016 /j.stem.2013 key aspect of the MII isoform switch that defines and delineates hematopoiesis ( Figure 7G ). How MYH10 is ultimately repressed in differentiation requires further study: RUNX1 downregulates MYH10 during MK differentiation (Lordier et al., 2012) , but RUNX1 does not anticorrelate in general with MYH10 and is not required for normal functions once HSCs are formed from vascular endothelial cells during embryonic development (Chen et al., 2009 ). Nevertheless, asymmetric processes are hinted at by a number of polarizable proteins in our early CD34 + cells, including Cdc42, which polarizes in correlation with HSC aging (Florian et al., 2012) . Generic polarization of a protein in hematopoietic cells seems predictive of a role in asymmetric division (Beckmann et al., 2007) , but MIIB's role in physically breaking the symmetry of cytokinesis seems unique and motivates deeper study of biophysical factors that feed back into transcription programs and perhaps even regulate cancer stem cell differentiation (Cicalese et al., 2009 ).
Human HSC/Ps expand when cultured on flexible tropoelastin matrices plus serum and cytokines (Holst et al., 2010) and also expand when cultured serum-free on endothelial cells that secrete cytokines (Butler et al., 2012) . However, endothelial cells and secreted matrix on plastic could be locally soft or regionally rigid. On FN-coated hydrogels that are marrow-mimetic soft or else endosteal-like stiff, minimal cytokines in serum-free media can for some conditions enrich for early CD34 + cells, consistent with our finding that both soft gels and blebbistatin suppress MIIB polarization and enhance pS1943-MIIA in early CD34 + cells. Figure S4 , Figure S5 , and Table S4 .
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Myosin-II Regulates Adult Hematopoiesis crawl away with sufficient force (to break the intercellular bridge) tend to become polyploid (Zang et al., 1997) . HSC/Ps grow well as suspension cells that do not adhere and spread strongly on substrates compared to other solid tissue cell types, and they only possess a thin cortical cytoskeleton; cytokinesis defects are thus likely to favor polyploidy in these cell types. In a blood cancer line that only expresses MIIA, partial knockdown of MIIA indeed increases polyploidy in vitro as does blebbistatin and the cancer cells survive . In healthy human and mouse primary cells, however, such a process of endomitosis is usually seen only for MKs (among blood cells at least), which implies that other cell types are either never tetraploid or apoptose if they become so. Irreversible ablation in vivo of MIIA in primary blood cells indeed enhances apoptosis and depletes most dividing blood cell types ( Figures 5D-5G ). This seems consistent with cell death in blebbistatin treatments being downstream of MII inhibition. Although the specificity of this drug has been questioned (Shu et al., 2005) , the reversible 3-day treatment here with blebbistatin of primary CD34+ cells in vitro increases ploidy of viable MKs and enhances apoptosis of progenitors with slower dividing stem/progenitor cells dying only with more sustained drug treatments. Our pharmacological results with AHR inhibitors provide some functional evidence of a transcriptome-implicated link between a failure of these normal primary, nonadherent cells to divide and AHR upstream of p53 in apoptosis ( Figure 7G , right), but since AHR is primarily nuclear, any interaction with MII is likely to be indirect.
Translation
Mouse knockouts of MIIB are embryonic lethal , and since MIIA is at least weakly polarizable ( Figure 2D) , any deficiencies or mutations in MIIB might be partially compensated by MIIA. Inhibiting both isoforms transiently, as shown here, might be exploited to further maintain and perhaps expand HSCs and maybe other stem cells in suitably designed microenvironments. Importantly, given the successful long-term engraftment of drug treated cells, genes that are truly essential for hematopoiesis (profile in Figure 5Aii ) might be clearly identified. Enrichment of highly adherent stem cells by the methods here might require optimization of adhesion to both suppress motility and provide sufficient anchorage signals for viability. Our findings ultimately reveal not only a biophysical hierarchy of actomyosin forces in adult hematopoiesis but also some utility in controlling those forces to enrich for stem cells.
EXPERIMENTAL PROCEDURES MS-IF Cytometry
For intracellular flow cytometry, cells were fixed with 4% paraformaldehyde in PBS for 10 min, washed with PBS, and resuspended in 0.1% saponin in HBSS. The samples were then stained with antibodies against MIIA and MIIB for 30 min at room temperature, along with hematopoietic surface markers and Hoechst 33342, followed by secondary antibody staining conjugated with Alexa 488 and 647 (Invitrogen). The samples were analyzed on an LSR II (BD) to obtain the mean fluorescent intensity (MFI) values of MIIB and MIIA across different samples and subpopulations. Each value was normalized by a standard cell line (MFI from COS cells) to correct for differences in fluorescence intensities caused by laser fluctuations. Normalized MFI values from flow cytometry were then calibrated by MS results for MSCs ) that served as a standard to calculate the stoichiometric ratio between MIIB and MIIA of each sample.
Standard methods can be found in Supplemental Experimental Procedures for MS, microarray, gene correlation analysis, cell culture, confocal microscopy, micropipette analysis, construction of matrix-coated gels, and xenotransplantation, among other techniques.
Statistical Analyses
All statistical analyses were performed using GraphPad Prism 5. Unless otherwise noted, all statistical comparisons were made by unpaired two-tailed Student t test and were considered significant if p < 0.05. All dose-response data were fitted to sigmoidal dose-response with variable slope with x axis in a log scale. Fig. 6C reflects net production by MKs and, while dominated by Phase-II, it suggests a roughly first order process with MK half-life regardless of drug treatment of 25~28 hrs; this is ~10 times longer than the same analysis for intravenous infused MKs and seems suggestive of intrabone transplantation (n=10 recipients ± SEM). (F) Human-CD41 + platelets derived in vivo after transplantation into NSC mice show the normal platelet size compared to human blood platelets. ANOVA P<0.0001. *P<0.05 for untreated in vitro vs in vivo. **P<0.01 for Blebb-exposed in vitro vs in vivo. ***P<0.001 for untreated in vivo vs mouse plt. n = 5 per sample (± SEM). (G) Colony forming assays demonstrate reduced progenitor numbers by myosin inhibition. CFU-GM IC50 = ~10.5 µM, Hill coefficient = -6; BFU-E IC50 = 18.6 µM, Hill coefficient = -20 (n ≥ 3 donors, ± SEM). Note that BFU-E and CFU-GEMM numbers are not changed under ~15 µM, while CFU-GM number is significantly reduced. Figure 1) The list of correlated genes with MYH10 based on the "robust to analysis" criteria. Figure 3 ) Gene correlation list of candidate genes involved in asymmetric division and polarization. Figure 4 , 6, 7) Expression profiles of selected genes relevant to signaling of myosin-IIA heavy chain phosphorylation, hematopoietic lineage differentiation, and apoptosis. NT: Non-Treated; TR: Blebb-Treated. 
Supplemental Experimental Procedures
Cell culture. Fresh purified bone marrow-derived human CD34 + cells were obtained from either the Penn Xenograft Core Facility or AllCells (Emeryville, CA). Cells from at least 20 different donors were used in this study. Purity of the samples (>98 %) was confirmed by flow cytometry with monoclonal antibody against human CD34. All experiments were performed in HSC expansion media (StemLine, Sigma) supplemented with 1x antibiotics, 20% BIT 9500 Serum Substitute (StemCell Technologies), 2 mM L-glutamate (Gibco) and the following human recombinant cytokines: stem cell factor (SCF, 100 ng/ml) and thrombopoietin (Tpo, 100 ng/ml). In some occasions, the media was also supplemented by granulocyte-colony stimulating factor (G-CSF, 100 ng/ml), epidermal growth factor (EGF, 100 ng/ml), transforming growth factor beta 1 (TGF-beta1, 100 ng/ml), erythropoietin (EPO, 1 U/ml) and interleukin-3 (IL-3, 10 ng/ml). All cytokines were purchased from R&D Systems. After cells were cultured for 4 days, they were treated with different doses of cellular contractility inhibitors, including (±)-blebbistatin (EMD Biosciences) and/or CH-223191 (Sigma) and StemRegenin-1 (Cellagen Technology, San Diego, CA) for indicated durations of up to 3 days. Cells were cultured at 37°C in 5% CO2.
Antibody staining and flow cytometry. Surface marker analysis for HSC/Ps was done on either a LSR II flow cytometer or FACSCalibur (Becton Dickinson). Fresh or cultured CD34 + -derived cells were stained in staining media (2% FBS in PBS) at room temperature for 1 h with PE or APCCy7 anti-CD34 (581, Invitrogen or Biolegend), PECy7 anti-CD38 (HIT2, eBioscience), PECy5.5 anti-CD45RA (MEM-56, Invitrogen), APC anti-CD90 (5E10, BD Bioscience), washed and stained with Hoechst 33342 (Invitrogen) at 37°C for 30min to stain nuclei, followed by washing with staining media with 7-AAD (Sigma) to exclude dead cells. Cells isolated from the bone marrow stained for 1 h with APC anti-mouse CD47 (miap301, AbD Serotec), FITC anti-human CD47 (BD Biosciences), and PE anti-human CD11b, PE anti-human CD19 (both from BD Biosciences), or PE anti-human Glycophorin A (Invitrogen). Platelets and RBCs were analyzed by staining with PE anti-mouse CD41 (eBioscience) and FITC anti-human CD41 (eBioscience) for 20min, followed by analysis on FACSCalibur on log forward and side scatter scales.
Intracellular flow cytometry. The method was modified from a protocol described previously (Gibbs et al., 2011) for HSC/Ps. Cells were fixed with 4% paraformaldehyde in PBS for 10 min, washed with PBS and resuspended in 0.1% saponin in HBSS (staining medium). The samples were then stained with antibodies against cytoplasmic antigens, including MIIA (Sigma), MIIB, phospho-MIIA, pan-p53, and caspase-3 (all from Cell Signaling Technology) for 30 min at room temperature. In some cases, cells were concurrently stained with PE anti-CD34 or anti-human CD38 for subpopulation analysis. Cells were then washed and stained with anti-rabbit or mouse secondary antibodies conjugated with Alexa 647 (Invitrogen) for 30 min, followed by analysis on FACSCalibur.
CFSE labeling. CD34 + -derived cells were labeled with CFSE (2.5 µM) in PBS/5% FBS for 3 min
Page 4 of 4 in dark at room temperature and washed once with PBS/5% FBS and once with HSC expansion media. The labeled cells were analyzed every day for 3 days using multi-color flow cytometry with HSC/P markers. Given that cell division is unsynchronized, cell numbers from different CFSE peaks are normalized by dividing the cell numbers by 2 division number to correct for the effect of cell expansion. The mean division number from each sample was calculated by fitting normalized CFSE data to the normal distribution curve and taking its mean value. The cell decay rate was calculated as described previously (Gett and Hodgkin, 2000) : Each peak represents a cohort of cells that entered their first division at the same time, and so one can calculate how many cells of each type underwent each division with the decay in cell number versus division number reflecting proliferation, differentiation, and cell death.
DNA Microarray Transcriptional Profiling and Gene Expression Correlation Analysis.
Total RNA was extracted from cells using Trizol and isolated by RNeasy (Qiagen) according to manufacturer's protocol. Total RNA was amplified and converted to cDNA using WT-Ovation Pico kit (NuGen) and converted to ST-cDNA, fragmented and biotin-functionalized using WTOvation Exon Mudule (NuGen). Hybridization cocktails were prepared at 45.4, 15.1 and 7.6 ng/µl ST-cDNA and mixed with Eukaryotic Hybridization Controls (GeneChip) at proportional concentrations. Each Sample was interrogated by sequential hybridization, rinse and scan cycles on a single Human Gene 1.0 ST DNA microarray (Affymetrix), from low to high concentration, and followed by two rinse-scan cycles in which no sample was added. In each experiment the scanned intensities that were obtained from all samples, five scans per array, were mutually RMA-summarized to transcription clusters gene levels so that the average and standard deviation values (STD) could be calculated for each gene ("Titrated-RMA"). In addition, raw intensities as a function of relative sample concentration were fitted by standard binding curves so that non-saturating and background-subtracted levels were evaluated ("SPEC method", Detailed description is available in Buxboim et al., 2012) . Average gene-expression levels ± STD of fresh HSC, MPP and CPP, and cultured CD34 + and CD34 -treated or untreated with blebbistatin samples were evaluated by averaging across five array scans. Values from each sample were averaged from two biologically independent experiments. Color-coded gene symbols represent the absolute gene expression levels of the biologically replicated averages of across samples. Pearson Correlation (MeV) was used to perform correlation analyses of the entire genome against MYH10, as well as to cluster samples and genes. Dendograms (Fig. 6A , ii) represent the correlative proximity of log-base-2 gene expression fold changes.
Cell culture and transfection in COS-1 cells. COS-1 cells were obtained from ATCC (Manassas, VA) and were maintained in high glucose DMEM with 10% FBS. Lipofectamene 2000 was used for both siRNA knockdown of MIIB and overexpression of MIIA constructs, according to the manufacturer's instruction (Invitrogen), when cells were 5-10% and 60-70% confluent, respectively. Efficiency of MIIB siRNA was confirmed to be >90% as indicated by quantitative immunofluorescence analysis. For GFP-tagged MIIA constructs, the transfection efficiency was about 30~40%. Cells were then subjected to micropipette aspiration or replated on FN-coated gels to study cell spreading.
